Early Alzheimer’s Egg-Shell Protein Therapy Shows Promise in Small Human Study 4 months ago ByJohnIn Clinical TrialsStartups
Ultragenyx Gene Therapy Rejected by FDA Even as Takeda Scores Big in Narcolepsy Trial 6 months ago ByJohnIn Clinical TrialsFDA Approvals
FDA Rejects UltraGeneX’s Gene Therapy Application, Pivotal Phase III Reads Out for Takeda Narcolepsy Drug 6 months ago ByJohnIn Breaking NewsFDA Approvals
CSL Enters Major Partnership with VarmX to Advance Bleeding Management Drug 6 months ago ByJohnIn Biopharma HighlightsPartnerships
New Phase 1/2 Study Shows Promise for Oral Alzheimer’s Drug in Early Alzheimer’s Disease 6 months ago ByJohnIn Breaking NewsBreakthroughsInnovationTop Stories
Setrusumab Trial Update Disappoints Investors Despite Continued Clinical Progress 6 months ago ByJohnIn InvestmentsVenture Capital
New Regulatory Shift: NIH Requires Alternatives to Animal-Only Studies in Funded Research 6 months ago ByJohnIn Breaking NewsTop Stories
Strong Real-World Data Strengthens Case for Long-Acting HIV Injectables 6 months ago ByJohnIn Biopharma Highlights
4 FDA Rejects UltraGeneX’s Gene Therapy Application, Pivotal Phase III Reads Out for Takeda Narcolepsy Drug